clinical trial | Q30612 |
P3098 | ClinicalTrials.gov ID | NCT04645212 |
P17 | country | United States of America | Q30 |
P582 | end time | 2025-06-01 | |
P921 | main subject | age related macular degeneration | Q830308 |
eye disease | Q3041498 | ||
choroidal neovascularization | Q5105209 | ||
Advmaker | Q18091499 | ||
Gene Therapy | Q57136618 | ||
P1050 | medical condition | macular degeneration | Q27429789 |
P2899 | minimum age | 50 | |
P1132 | number of participants | 30 | |
P8005 | research subject recruitment status | enrolling by invitation | Q92331923 |
P580 | start time | 2020-12-14 | |
P8363 | study type | observational study | Q818574 |
P1476 | title | A Long-term Study of ADVM-022 in Neovascular (Wet) AMD - OPTIC Extension |
Search more.